With a market capitalization (market cap) of $4.36B — a measure of how much the company is worth — Parabilis Medicines, Inc. is the 1526th most valuable company in Healthcare as of August 12, 2026. Shares trade at $37.41, up +2.58% on the day.
of 2,600
price ÷ annual EPS
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Visit websiteAs of August 12, 2026, Parabilis Medicines, Inc. (PBLS) is worth $4.36B — this is its market capitalization, the total value of all its outstanding shares.
Parabilis Medicines, Inc.’s market cap is $4.36B, which ranks it #1526 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Parabilis Medicines, Inc. (PBLS) shares trade at $37.41, up 2.58% on the day, as of August 12, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.